Jaskirat Singh Randhawa , MD

Undergraduate Degree: Khalsa College of Amritsar 2001 (Medicine)

Medical Degree: Government Medical College Amritsar 2007

Residency: Cleveland Clinic Foundation at Fairview Hospital Cleveland, Ohio, 2011

Hematology Oncology

Peer Reviewed Publications

Randhawa, Jaskirat; Thiruchelvam, Nirosshan; Ghobrial, Michael; Spiro, Timothy; Clark, Bernadette; Haddad, Abdo; Daw, Hamed (2014. ) Practical recommendations on incorporating new oral anticoagulants into routine practice. Clinical advances in hematology & oncology : H&O, , 12 (10 ) ,675-83

Randhawa, Jaskirat S; Budd, George T; Randhawa, Mandeep; Ahluwalia, Manmeet; Jia, Xuefei; Daw, Hamed; Spiro, Timothy; Haddad, Abdo (2014. ) Primary Cardiac Sarcoma: 25-Year Cleveland Clinic Experience.American journal of clinical oncology, , More Information

Thiruchelvam, Nirosshan; Randhawa, Jaskirat; Sadiek, Happy; Kistangari, Gaurav (2014. ) Teriparatide induced delayed persistent hypercalcemia.Case reports in endocrinology, , 2014 ,802473 More Information

Randhawa, Jaskirat; Ondrejka, Sarah L; Setrakian, Sebouh; Taylor, Harris (2013. ) What should I know before ordering a bone marrow aspiration/biopsy in patients with vitamin B12 deficiency?.BMJ case reports, , 2013 , More Information

Randhawa, Jaskirat; Onyshchenko, Mykola; Mbuvah, Farayi; Bagai, Rajesh (2014. ) A Rare Association of Fahr's Disease With an Autoimmune Triad.The Journal of neuropsychiatry and clinical neurosciences, , 26 (4 ) ,E16-8 More Information

Arun Sendilnathan, MD, Jaskirat Singh Randhawa, MD, Changchun Xie, Rebecca Bolt, RN, Thomas Leemhuis, Nora Buzek, Kitty Tierney, Susan Pinkard, Saulius Girnius, MD, and Stephen Medlin, DO, FACP (2015. ) Low-Dose Cyclophosphamide Plus Granulocyte Colony-Stimulating Factor As an Efficacious and Safe Peripheral Blood Stem Cell Mobilizing Regimen in Patients with Hematologic Malignancies .Blood, , 126 (23 ) ,5438

Haque, Sulsal; Yellu, Mahender; Randhawa, Jaskirat; Hashemi-Sadraei, Nooshin (2017. ) Profile of pembrolizumab in the treatment of head and neck squamous cell carcinoma: design development and place in therapy.Drug design, development and therapy, , 11 ,2537-2549 More Information

Poster Presentations

Jaskirat Singh Randhawa, Sina Shafiei, Mykola Onyshchenko, Susmita Sakruti, Rohan Garje, Vyshak Alva Venur, Xuefei Jia, Timothy Peter Spiro, Abdo S. Haddad, Hamed Daw (06-2014. ) Predictive factors for late (>5 years) distant recurrences in estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer patients: >20-year follow-up .ASCO Annual Meeting, J Clin Oncol 32:5s, 2014 (suppl; abstr 543), Chicago. . Level:National

Academic - Vontz Center for Molecular Studies
3125 Eden Avenue
Cincinnati  Ohio, 45267
Phone: 513-558-2119
Fax: 513-558-2124
jaskirat.randhawa@uc.edu